Probiotic sales soar in the epidemic, the future trends are unpredictable

As new coronaviruses continue to spread, consumer demand for dietary supplements continues to grow, and immune products, including probiotics, are the most sought after. NutraIngredients interviewed leading probiotic suppliers in the industry to understand the impact of the epidemic on supply and their predictions for the next 3 to 6 months.

Scott Ravech, CEO of Deerland Probiotics & Enzymes, a contract manufacturer of enzyme supplements, said: "Our probiotic and enzyme product orders have achieved double-digit growth, greatly exceeding expectations, and expected future consumption The demand for dietary supplement products will continue to increase. After the epidemic, the growth momentum will continue. "It is reported that the company has already purchased all applicable raw materials and PPE in advance in mid-March to ensure domestic and foreign supply stability.

Isabelle Champié, sales and marketing director of Lallemand Health Solutions, said that compared with February and March last year, the demand for probiotics in various places increased by 15% to 20%, but forecast In the spring of 2020 (April and May), the sales of probiotics will be affected by the epidemic blockade, which may decline by 5% to 10% year-on-year.

Kevin Mehring, President and CEO of UAS Labs, a probiotic company in the United States, said: "The United States and Canada are major producers of probiotic raw materials, so UAS Labs' domestic supply has not been affected. It is expected that the next 3 to 6 months Supply will maintain current levels. "